In this study, researchers used the AHA’s PREVENT equation to evaluate cardiovascular disease risk in cisplatin-treated testicular cancer survivors.
Based on the PREVENT risk calculator, researchers developed age- and sex-specific percentiles for 30-year absolute risk estimates for cardiovascular disease. Framing risk relative to peers by age and ...
Cardiovascular disease (CVD) is a potential adverse effect of endocrine treatment (ET) for prostate cancer (PC). We investigated absolute and relative CVD risk in 76,600 patients with PC undergoing ET ...
Empagliflozin vs placebo was associated with greater reductions in risk for cardiovascular disease among patients with type 1 diabetes. Sodium–glucose cotransporter inhibitors (SGLTis) are associated ...
A new study raises concerns that the PREVENT calculator may underestimate cardiovascular risk in some young adult populations.
A new tool may help patients better understand their long-term cardiovascular risk, researchers said. Based on the standard PREVENT risk calculator, researchers developed population-based age- and sex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results